Cargando…

Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli

With increased accessibility and tissue penetration, smaller antibody formats such as antibody fragments (Fab) and single chain variable fragments (scFv) show potential as effective and low-cost choices to full-length antibodies. These formats derived from the modular architecture of antibodies coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tungekar, Aatir A., Ruddock, Lloyd W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469194/
https://www.ncbi.nlm.nih.gov/pubmed/37648872
http://dx.doi.org/10.1038/s41598-023-41525-3
_version_ 1785099388584984576
author Tungekar, Aatir A.
Ruddock, Lloyd W.
author_facet Tungekar, Aatir A.
Ruddock, Lloyd W.
author_sort Tungekar, Aatir A.
collection PubMed
description With increased accessibility and tissue penetration, smaller antibody formats such as antibody fragments (Fab) and single chain variable fragments (scFv) show potential as effective and low-cost choices to full-length antibodies. These formats derived from the modular architecture of antibodies could prove to be game changers for certain therapeutic and diagnostic applications. Microbial hosts have shown tremendous promise as production hosts for antibody fragment formats. However, low target protein yields coupled with the complexity of protein folding result in production limitations. Here, we report an alternative antibody fragment format ‘Fab(H)3’ designed to overcome some key bottlenecks associated with the folding and production of Fabs. The Fab(H)3 molecule is based on the Fab format with the constant domains replaced by engineered immunoglobulin G1 (IgG(1)) C(H)3 domains capable of heterodimerization based on the electrostatic steering approach. We show that this alternative antibody fragment format can be efficiently produced in the cytoplasm of E. coli using the catalyzed disulfide-bond formation system (CyDisCo) in a natively folded state with higher soluble yields than its Fab counterpart and a comparable binding affinity against the target antigen.
format Online
Article
Text
id pubmed-10469194
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104691942023-09-01 Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli Tungekar, Aatir A. Ruddock, Lloyd W. Sci Rep Article With increased accessibility and tissue penetration, smaller antibody formats such as antibody fragments (Fab) and single chain variable fragments (scFv) show potential as effective and low-cost choices to full-length antibodies. These formats derived from the modular architecture of antibodies could prove to be game changers for certain therapeutic and diagnostic applications. Microbial hosts have shown tremendous promise as production hosts for antibody fragment formats. However, low target protein yields coupled with the complexity of protein folding result in production limitations. Here, we report an alternative antibody fragment format ‘Fab(H)3’ designed to overcome some key bottlenecks associated with the folding and production of Fabs. The Fab(H)3 molecule is based on the Fab format with the constant domains replaced by engineered immunoglobulin G1 (IgG(1)) C(H)3 domains capable of heterodimerization based on the electrostatic steering approach. We show that this alternative antibody fragment format can be efficiently produced in the cytoplasm of E. coli using the catalyzed disulfide-bond formation system (CyDisCo) in a natively folded state with higher soluble yields than its Fab counterpart and a comparable binding affinity against the target antigen. Nature Publishing Group UK 2023-08-30 /pmc/articles/PMC10469194/ /pubmed/37648872 http://dx.doi.org/10.1038/s41598-023-41525-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tungekar, Aatir A.
Ruddock, Lloyd W.
Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title_full Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title_fullStr Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title_full_unstemmed Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title_short Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli
title_sort design of an alternate antibody fragment format that can be produced in the cytoplasm of escherichia coli
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469194/
https://www.ncbi.nlm.nih.gov/pubmed/37648872
http://dx.doi.org/10.1038/s41598-023-41525-3
work_keys_str_mv AT tungekaraatira designofanalternateantibodyfragmentformatthatcanbeproducedinthecytoplasmofescherichiacoli
AT ruddocklloydw designofanalternateantibodyfragmentformatthatcanbeproducedinthecytoplasmofescherichiacoli